Life Sciences 公開
[search 0]
もっと

Download the App!

show episodes
 
With a bird’s-eye-view of the life sciences industry, Life Sciences Pennsylvania President & CEO, Chris Molineaux, joins Rachael Bushey, Partner and Chair of the Health Sciences Department at Troutman Pepper to welcome life sciences leaders to give insights into the complex and high-risk world of pharmaceuticals, biotechnology, medical devices, diagnostics and the services that support them. Here we learn what it means to be a life sciences leader.
 
Join our Keck Graduate Institute (KGI) community as we share behind-the-scenes insights on the innovation and collaboration taking place on campus. On this podcast, we share conversations with students, faculty, staff, alumni, and other guests. Visit our website at kgi.edu and follow us on social media @KeckGrad.
 
Investing in the life sciences 101. In this limited podcast series, we’ve brought together a series of conversations with experts from medical science to finance to help demystify investing in biotech, medtech and digital health (also known as the life sciences). This podcast has been brought to you by Life Sciences WA (Western Australia’s Life Sciences Industry Association) in collaboration with Talking HealthTech. It has been possible with funding support from the West Australian governmen ...
 
Join us on this podcast series as we meet the icons of the biotechnology industry, exploring the current state of innovation in Queensland and what the future holds for our best and brightest. Hosted by Anthony Frangi, each episode will feature a new guest sharing their unique angle on the capabilities of the industry in Queensland.
 
Leading Minds podcast by Life Sciences Voice delves deep inside the minds of the top life sciences executives, including pharmaceuticals, biotech, medical devices, consumer health, animal health, and leaders from related industries. In every episode, we meet a leader who has made a lasting impact in the life sciences industry and continues to drive the industry forward. We go beyond the name and the title to unravel their personality, their beliefs, their mission, and most importantly, to un ...
 
This is Politics & Life Sciences (PLS) Radio which is an interplay of Life Sciences and Politics. I am your host Dean L. Fanelli, Ph.D. I am an Intellectual Property attorney in Washington, DC. My practice focuses on issues attendant to the Life Sciences industry. On PLS, we will explores cutting edge topics involving the Biotech and Pharma ecosystems and looks at political or governmental policy issues affecting the Biotech and Pharma industries. Each week, PLS will have amazing guests incl ...
 
Life Sciences tönen nicht nur spannend, sondern sind es auch! Wir messen uns in Lehre und Forschung an internationalen Qualitätsstandards und fördern Transdisziplinarität sowie die Kooperation mit Netzwerken und vielfältigen Partnern. Unser Ziel ist es, den faszinierenden Life Sciences-Wissenschaften marktwirtschaftliche Anwendungen zu geben und gemeinsam mit Forschungspartnern ein international unverwechselbares Hochschulprofil zu etablieren. Im Zentrum unserer Aus- und Weiterbildung steht ...
 
Join Nancy Donohoo’s bi-weekly podcast, Talk at the Top, and get to know the key influencers in life sciences and healthcare who are positively impacting patients, providers, consumers and the industry itself! Nancy’s guests include groundbreakers and executives from across the healthcare spectrum: CEOs, physician executives, medical affairs and scientific leaders, venture capital and private equity investors, academics and entrepreneurs. This is your front row ticket to discussions on innov ...
 
Loading …
show series
 
Julie McHugh brings more than 30 years in the biopharmaceutical industry, and currently serves on multiple boards as a director. In this episode, learn about the importance of owning your work and empowering your team to take on new challenges through honesty. Julie discusses how learning the science behind your work will positively impact the comp…
 
In this episode of the KGI podcast, we sat down with Dr. Barbara Fortini, associate professor of genetics and the program director of the one-of-a-kind Master of Science in Human Genetics and Genomic Data Analytics (MSGDA) program, to discuss her background, history of the MSGDA program, and why it is important.…
 
In this episode of the KGI podcast, one of KGI's founding faculty members, Dr. James Sterling, program director of the PhD in Applied Life Sciences program, discusses his various roles at KGI and talks about the PhD program and the future of a doctorate degree.
 
Listen to Tara Muzsi discuss the importance of a hierarchy of priorities in decision-making that supported her work-life integration with a successful career at Janssen. Stream the episode now to hear Tara's tips on building a diverse team, the importance of culture and driving an innovation mindset.…
 
In this episode of the Life Sciences WA Podcast, Dr Tara Speranza discusses her work as a healthcare and biotech analyst at Bell Potter Securities. Dr Speranza is part of a group of three analysts who cover the healthcare and biotech sector in Australia, focusing on companies listed on the ASX. She has a background in molecular biology and endocrin…
 
Investment in life sciences in Western Australia is an area of great interest, as shown by the recent Life Sciences WA podcast episode featuring guests Greg Riebe and Steve Elias. Riebe is a company director and angel investor with decades of experience in commercialising emerging technologies and is currently a Commercialisation Facilitator for th…
 
This episode features conversations with Paul Watt, Co-Founder and Executive Chair of Avicena Systems and Liddy McCall, Director of Yuuwa Ventures Investment in life sciences in Western Australia has grown significantly in recent years. This growth has been driven by several factors, including the state's strong research and development infrastruct…
 
In this episode of the Life Sciences WA Podcast, Dr Bi Mian discusses his work with the Australian Medical Angels, a medical syndicate that focuses on investing in HealthTech start-ups in Australia. Dr Mian, who is a medical doctor and runs a multi-specialist medical centre in regional New South Wales, founded the group with his co-founder Dr Amand…
 
In this podcast episode of the Life Sciences WA Podcast, the guest was Bronwyn LeGrice, CEO of ANDHealth. The focus of the discussion was on investing and commercialising digital health. LeGrice introduced herself and discussed her background, which included seven years in venture capital and over 20 years in the commercialisation of medical techno…
 
Dr Alma Fulurija Dr Alma Fulurija is the Head of the Strep A Vaccines team at Telephone Kids Institute. In this interview, she discussed the process of vaccine development, which is a long, expensive, and high-risk process, but has the potential for high rewards if successful. The Covid-19 pandemic has shown that vaccine development can be done fas…
 
Glenn Butcher is the CEO of FundWA, a venture capital firm focused on investing in technology-enabled innovation businesses in Western Australia. In this interview, he discussed the potential for growth and success in this area, highlighting the state's strong track record in life sciences research and the potential for commercialising this researc…
 
Liam Kelly, Chairman, President, & CEO of Teleflex, discusses the importance of patient outcomes, and how the key to leadership in the industry is steadiness. Stream the episode now to learn how hard work, entrepreneurial spirit, and focus can lead to great success for you and your team.Life Sciences Pennsylvania による
 
Video interview with CEO & Founder of the i-Expand, a firm that helps Health Tech start-ups to scale with commercial success. The discussion covered multiple trends and topics within the Life Sciences industry, including access and affordability, advances in AI for drug discovery and development, precision medicines and diversity in healthcare.…
 
Hear from Peter Miller as he discusses his journey through successful entrepreneurship into the role of CEO at OptiNose. In this episode, Peter discusses board management, motivating a team, and how many leaders often confuse effort with success.Life Sciences Pennsylvania による
 
KGI joins Dr. Cynthia Martinez, Dean of the School of Community Medicine, for a second podcast to discuss KGI's ground-breaking Master of Science in Community Medicine program. The fully online, two-year program is revolutionizing how we educate future physicians, healthcare providers, and health professionals in the sciences and technologies that …
 
This is the fourth episode in our series of special podcasts for KGI’s 25th anniversary. In this episode, we listen to KGI's Dr. Kiana Aran talk about her journey to freedom through science. Dr. Paul Grint moderates the talk. This was recorded on November 1, 2022, in San Diego as part of KGI's Speaker Series.…
 
This week's guest, Bruce Shook, brings 40 years of experience pioneering new medical technologies in cardiology, cardiac surgery, neurosurgery, psychiatry and peripheral vascular disease. He has raised more than $400 million in private equity for numerous companies, and most recently served as the CEO of two organizations that were sold to Philips …
 
This is the third episode in our series of special podcasts for KGI’s 25th anniversary. In this episode, we share a delightful conversation between KGI President Sheldon Schuster as he talked with integral founding members of the institute: Bonnie Busenberg, Stephen McCormack, Bob Curry, and Greg Dewey. The group reminisced about the early days at …
 
Season 2 of Being a Life Sciences Leader is here! Our first episode welcomes guest Ron Philip, CEO of Spark Therapeutics in front of a live studio audience. Stream the episode to hear how Ron’s childhood as an immigrant to the U.S. helped forge a path in the life sciences that led to his current position. Ron discusses the importance of building a …
 
In this episode of the KGI podcast, we feature KGI Board of Trustees member Dr. Carol Nacy, who gave an Industry Talk to the KGI community on October 13, 2022. Nacy is a founder and the Chief Executive Officer of Sequella, Inc., a privately-held pharmaceutical company that discovers and develops treatments for life-threatening infectious diseases. …
 
My guest today is Executive Director, Co-Founder and Chief Scientific Officer at Microbio, Doctor Flavia Huygens. Flavia’s 30-year teaching and research career has focused on molecular microbiology, with a particular emphasis on human pathogens.Life Sciences Queensland による
 
This is the second episode in our series of special podcasts for KGI’s 25th anniversary. In this episode, we hear from former KGI School of Community Medicine Dean Dr. David Lawrence on the future of healthcare. The discussion was recorded on October 7, 2022, during KGI’s Founder’s Day celebration. KGI appointed former Kaiser CEO Dr. David M. Lawre…
 
Leading Minds podcast by Life Sciences Voice delves deep inside the minds of the top life sciences executives, including pharmaceuticals, biotech, medical devices, consumer health, animal health, and leaders from related industries. In every episode, we meet a leader who has made a lasting impact in the life sciences industry and continues to drive…
 
This episode kicks off a series of special podcasts for KGI's 25th anniversary. In this episode, we hear from KGI Board of Trustee members Dr. Ross Grossman, Teresia Bost, and Dr. Lydia Villa-Komaroff on the future of biotech and the life sciences. The discussion was recorded on October 7, 2022, during KGI's Founder's Day celebration. Grossman serv…
 
Joining Slice of Life Sciences Real Estate today is Roger Frechette who is a life sciences consultant/advisor, helping early-stage life science companies to succeed and to grow. His work with clients leverages an extensive global network and multi-disciplinary insights derived from over 20 years of experience in the business of life sciences, calib…
 
Hi everyone and welcome to episode #12 of Slice of Life Sciences. We have a great conversation lined up today as we are joined by Chris Bahl, Chief Scientific Officer and Co-Founder of AI Proteins. I have gotten to know Chris this past year, which makes me especially excited to hear about his journey and how it led to this newly founded biotech com…
 
Thanks everybody for joining us on episode #11 of Slice of Life Sciences. I’m very much looking forward to today’s episode as I am joined by Jake Lombardo, Co-Founder and CEO at Anodyne Nanotech, which is a venture-backed, preclinical-stage biotech company developing differentiated, transdermal forms of high-value drugs. In this episode you'll lear…
 
KGI talks with Dr. Cynthia Martinez, newly appointed Dean of the School of Community Medicine. “Everything about the mission and vision of the School of Community Medicine is reflected in my personal lived experiences,” Martinez explained. “I am coming full circle as I get to apply my Bachelor of Science in Biology and my experience working in heal…
 
KGI talks with Christy Eskes, newly appointed Program Director of the Master of Science in Physician Assistant Studies program. Eskes has worked in various roles in PA education since 2009 as a Didactic Coordinator, Program Director, and Associate Program Director. She briefly stepped away from full-time PA education in 2016, continuing to work cli…
 
Valerie Asbury joined Chris Molineaux and Rachael Bushey on stage at Life Sciences Future - MedTech to discuss the importance of building courage within employees, and why working in a start-up can be the most meaningful career. Hear Val's challenges with spinning out LifeScan during the pandemic, and why she always asks her employees "what keeps y…
 
The pandemic drastically altered the landscape for investment flowing into the Life Sciences. Not only was there more money going in, but the market needs changed too, with an unprecedented focus on scaling sectors like testing and vaccines. But what did this mean for sectors which were not on the Covid front line? What happened to the trends that …
 
Dr. Neal Walker takes the mic to discuss how the pull of working at a start-up inspired him to take the same path. Learn lessons from Dr. Walker's successful exits, the importance of lifelong learning for continued success, and why entrepreneurs should have contingencies in place in case the business needs to pivot.…
 
Good afternoon everyone and welcome back to Slice Of Life Sciences. I’ve been super eager to get to today’s session given our guest and what his company has done and is continuing to do as they are pioneering Tissue Therapeutics. I typically like you give an overview of the person and company, but today I am going to keep it short and sweet so we c…
 
In the past decade, two events have sent shockwaves through the diagnostics industry: Theranos and Covid. The first, is a parable against faking it in an industry which rightly prizes accuracy and safety. The second was an almost insatiable demand for diagnostic testing kits, where the speed of information took second place to accuracy. Was Elizabe…
 
Bryant Lim, S.V.P. and General Counsel for Idera Pharmaceuticals joins Chris Molineaux and Rachael Bushey to discuss how he avoided the title of "Dr. No." Hear Bryant's advice on mitigating risk while also encouraging innovation as a general counsel in the life sciences. Send questions for future guests to membership@lifescienespa.org…
 
Following our first episode of two focusing on cell and gene therapies, outlining the promise and practicalities of delivering curative therapies for chronic diseases, we now focus on cell therapies - so called ‘living drugs’ that are both as powerful as they are complex. Despite the impressive trials and life-changing impacts at the individual lev…
 
Ren Capocasale joins Chris and Rachael to discuss the recent acquisition of the CRO arm of his organization, FlowMetric. Hear Ren’s advice on what to prioritize when seeking partnerships, how failures can be the biggest motivators, and how Ren’s team pivoted during the pandemic. Send questions for future guests to membership@lifescienespa.org…
 
With therapies like cell and gene - amongst some of the most significant innovations in modern medicine - the idea of delivering cures for conditions from cancer to diabetes is now within the realm of scientific possibility. But will it be possible to provide the benefits of advanced therapies to all? Should we expect our healthcare systems to foot…
 
Julian Ritchey, U.S. Head of Vaccines Public Affairs and Advocacy at Sanofi Pasteur, joins Chris and Rachael on the mic. Learn about how Julian combatted issues of vaccine confidence through the pandemic, his work with patient advocacy groups, and the most rewarding aspects of working in the life sciences. Listeners will gain insight on how to appr…
 
From cosmetics to medicines, animal testing is still widely mandated by regulators. Up to now, there have been few other ways to gather information about the potential human response to drug candidates. But are animal models still the most effective way to test drugs before we use them in humans? Or are these in vivo models outdated, ready to be re…
 
Gerri Henwood, President & CEO of Baudax Bio takes the mic with years of experience behind her. She explains her journey in the life sciences, with anecdotes on receiving FDA approvals, taking an organization public, and investor relations. Learn how Gerri empowers her employees, and the importance of trusting your team. Send questions for future g…
 
The hunt to discover new pharmaceuticals in areas of high unmet need can be complex, time-consuming, and costly. For every life saving therapy that hits the market, thousands and even millions of candidate drugs are rejected. A new technology could be changing the way we home in on the most effective therapy: AI. The use of AI in drug discovery - w…
 
President & CEO of Harmony Biosciences John Jacobs joins Chris and Rachael to discuss his rise from sales manager to life sciences executive. Hear anecdotes of the growing pains that come with leadership, and how a painting of Boat House Row in Philadelphia changed the trajectory of his journey. Submit question for future guests to membership@lifes…
 
In this episode, Mimi Yen, CEO & Co-Founder at PhagePro joins host David Thomann for episode #9 of Slice of Life Sciences Real Estate podcast. Today makes for another great discussion as we have Mimi Yen, CEO and Co-Founder of PhagePro, which she co-founded in 2016 and is an early-stage biotechnology therapeutics company that develops bacteriophage…
 
What is the potential of synthetic biology? A chance to create life-changing therapies by speaking cells’ very own language? Or could rogue researchers use it to turn our own biology against us? Since synthetic biology emerged as a field, the aspirations for its benefits have been as speculative as the concerns about its misuse, making one of the m…
 
Meet this week's guest, Steve Tullman, known for his expertise in mergers, acquisitions and multiple successful exits. Listen to Steve's journey in founding life sciences companies, his current projects, and hear his insights into investor relations. Have questions for future guests? Email membership@lifesciencespa.org.…
 
Loading …

クイックリファレンスガイド

Google login Twitter login Classic login